These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35017140)

  • 1. Primary Enteric Adenocarcinoma Lung with Mesenchymal Epithelial Transition Factor Amplification: A Case Report.
    Shukla S; Pandey RK; Husain N; Srivastava A
    Gulf J Oncolog; 2021 May; 1(36):76-78. PubMed ID: 35017140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.
    Wang CX; Liu B; Wang YF; Zhang RS; Yu B; Lu ZF; Shi QL; Zhou XJ
    Int J Clin Exp Pathol; 2014; 7(3):1266-74. PubMed ID: 24696747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry.
    Zhang J; Xiang C; Han Y; Teng H; Li X; Shao J; Zhu L; Han-Zhang H; Ye J; Yu K
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):269-279. PubMed ID: 30415301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.
    Rossing HH; Grauslund M; Urbanska EM; Melchior LC; Rask CK; Costa JC; Skov BG; Sørensen JB; Santoni-Rugiu E
    BMC Res Notes; 2013 Nov; 6():489. PubMed ID: 24279718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and genetic analyses of pulmonary enteric adenocarcinoma.
    Okada F; Takeda M; Fujii T; Uchiyama T; Sasaki S; Matsuoka M; Nitta Y; Terada C; Maebo K; Morita K; Ishida E; Sawabata N; Ohbayashi C
    J Clin Pathol; 2024 Jan; 77(2):111-115. PubMed ID: 36456172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens.
    Zhao L; Huang S; Liu J; Zhao J; Li Q; Wang HQ
    Medicine (Baltimore); 2017 Sep; 96(39):e8153. PubMed ID: 28953659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pulmonary enteric adenocarcinoma patient harboring a rare EGFR exon 19 P753S mutation: Case report and review.
    Xu X; Chen D; Wu X; Wang Q
    Front Oncol; 2022; 12():988625. PubMed ID: 36212391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.
    Zuo Y; Zhong J; Bai H; Xu B; Wang Z; Li W; Chen Y; Jin S; Wang S; Wang X; Wan R; Xu J; Fei K; Han J; Yang Z; Bao H; Shao Y; Ying J; Song Q; Duan J; Wang J
    EBioMedicine; 2022 Aug; 82():104165. PubMed ID: 35901658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of Oncogenic Driver Events in Lung Adenocarcinoma Revealed MET Mutation as Independent Prognostic Factor.
    Yeung SF; Tong JHM; Law PPW; Chung LY; Lung RWM; Tong CYK; Chow C; Chan AWH; Wan IYP; Mok TSK; To KF
    J Thorac Oncol; 2015 Sep; 10(9):1292-1300. PubMed ID: 26098749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristics.
    Kwon D; Koh J; Kim S; Go H; Kim YA; Keam B; Kim TM; Kim DW; Jeon YK; Chung DH
    Lung Cancer; 2017 Apr; 106():131-137. PubMed ID: 28285687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROS-1 re-arrangements and c-MET amplifications in adenocarcinoma lung: A tertiary care center study from North India.
    Shukla S; Pandey RK; Kant S; Garg R; Husain N
    Indian J Pathol Microbiol; 2019; 62(3):433-436. PubMed ID: 31361233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary enteric adenocarcinoma.
    Gong J; Fan Y; Lu H
    Transl Oncol; 2021 Aug; 14(8):101123. PubMed ID: 34000642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.
    Garajová I; Funel N; Fiorentino M; Agostini V; Ferracin M; Negrini M; Frassineti GL; Gavelli G; Frampton AE; Biasco G; Giovannetti E
    Clin Epigenetics; 2015; 7():129. PubMed ID: 26677401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Enteric Adenocarcinoma Harboring a BRAF G469V Mutation.
    Shimizu D; Yamamoto H; Shien K; Taniguchi K; Miyoshi K; Namba K; Mesaki K; Sugimoto S; Soh J; Yamane M; Toyooka S
    Acta Med Okayama; 2021 Dec; 75(6):759-762. PubMed ID: 34955547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic mutation profiles and immune microenvironment analysis of pulmonary enteric adenocarcinoma.
    Xie M; Chen D; Li Y; Liu X; Kuang D; Li X
    Diagn Pathol; 2022 Feb; 17(1):30. PubMed ID: 35172862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity.
    Ko SJ; Lee YJ; Park JS; Cho YJ; Yoon HI; Chung JH; Kim TJ; Lee KW; Kim K; Jheon S; Kim H; Lee JH; Lee CT
    BMC Cancer; 2014 May; 14():312. PubMed ID: 24885886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotype.
    Kim H; Jang SJ; Chung DH; Yoo SB; Sun P; Jin Y; Nam KH; Paik JH; Chung JH
    PLoS One; 2013; 8(10):e76999. PubMed ID: 24194854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological and molecular features of pulmonary enteric adenocarcinoma].
    Gao G; Wang YZ; Zhang YP; Feng SE; Hou M; Xia QX
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):544-549. PubMed ID: 32486530
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
    Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
    Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
    Villaruz LC; Socinski MA; Abberbock S; Berry LD; Johnson BE; Kwiatkowski DJ; Iafrate AJ; Varella-Garcia M; Franklin WA; Camidge DR; Sequist LV; Haura EB; Ladanyi M; Kurland BF; Kugler K; Minna JD; Bunn PA; Kris MG
    Cancer; 2015 Feb; 121(3):448-56. PubMed ID: 25273224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.